Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
McKinsey
AstraZeneca
Covington
Cipla
Chubb
Baxter
Accenture
Cerilliant
Boehringer Ingelheim

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,001,153

« Back to Dashboard

Summary for Patent: 5,001,153
Title: Ocular hypotensive agents
Abstract:The present invention relates to ocular hypotensive agents which contains 13,14-dihydro-15-keto-prostagrandins, which shows no transient ocular hypertensive response that PGs usually show.
Inventor(s): Ueno; Ryuzo (Nishinomiya), Ueno; Ryuji (Nishinomiya), Oda; Tomio (Itami, JP)
Assignee: K.K. Ueno Seiyaku Oyo Kenkyujo (Osaka, JP)
Application Number:07/246,059
Patent Claim Types:
see list of patent claims
Composition; Use; Dosage form;

Drugs Protected by US Patent 5,001,153

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,001,153

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan62-235890Sep 18, 1987
Japan62-334037Dec 29, 1987

International Patents Family Members for US Patent 5,001,153

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 108330 ➤ Try a Free Trial
Austria 111736 ➤ Try a Free Trial
Austria 162074 ➤ Try a Free Trial
Austria 72235 ➤ Try a Free Trial
Austria 82499 ➤ Try a Free Trial
Australia 2223088 ➤ Try a Free Trial
Australia 2231388 ➤ Try a Free Trial
Australia 600168 ➤ Try a Free Trial
Canada 1324129 ➤ Try a Free Trial
Canada 1328075 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Covington
Deloitte
Chinese Patent Office
McKinsey
Queensland Health
Citi
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot